Richard D. Kim
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Hepatology 33
- Hepatocellular Carcinoma Treatment and Prognosis 32
- Oncology 54
- Pancreatic and Hepatic Oncology Research 21
- Colorectal Cancer Treatments and Studies 20
- Co-authors
- Amit Mahipal (19 shared papers)Dae Won Kim (6 shared papers)Chetasi Talati (1 shared paper)Michael Andrew Morse (2 shared papers)Aiwu Ruth He (2 shared papers)Weijing Sun (1 shared paper)Richard S. Finn (1 shared paper)Paolo Abada (1 shared paper)
- Journals
- Cancers (7 papers)The Oncologist (6 papers)Cancer (6 papers)Expert Opinion on Investigational Drugs (5 papers)Clinical Colorectal Cancer (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Richard D. Kim
147 papers receiving 4.5k citations
Richard D. Kim's Hit Papers
Peers
Comparison fields: 5 of 123
- Hepatology 780
- Oncology 1.3k
- Cancer Research 593
- Pathology and Forensic Medicine 454
- Surgery 1.0k
Countries citing papers authored by Richard D. Kim
This map shows the geographic impact of Richard D. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Kim more than expected).
Fields of papers citing papers by Richard D. Kim
This network shows the impact of papers produced by Richard D. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Kim. The network helps show where Richard D. Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard D. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of Angiogenesis in Hepatocellular Carcinoma Hit paper breakdown → | 2018 | 449 |
| 2 | 2008 | 378 | |
| 3 | A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer Hit paper breakdown → | 2020 | 351 |
| 4 | 2017 | 267 | |
| 5 | 2019 | 218 | |
| 6 | 2004 | 137 | |
| 7 | 2012 | 130 | |
| 8 | 2012 | 100 | |
| 9 | 2019 | 96 | |
| 10 | 2015 | 86 | |
| 11 | 2018 | 86 | |
| 12 | 2011 | 82 | |
| 13 | 2018 | 69 | |
| 14 | 2018 | 68 | |
| 15 | 2022 | 65 | |
| 16 | 2019 | 60 | |
| 17 | 2016 | 47 | |
| 18 | 2020 | 47 | |
| 19 | 2021 | 47 | |
| 20 | 2022 | 47 |
About Richard D. Kim
Richard D. Kim is a scholar working on Hepatology, Oncology, Surgery, Pathology and Forensic Medicine and Cancer Research, having authored 156 papers that have together received 4.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers), Pancreatic and Hepatic Oncology Research (21 papers), Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (11 papers), Genetic factors in colorectal cancer (10 papers), Colorectal and Anal Carcinomas (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Hepatology (780 citations), Oncology (1.3k citations), Cancer Research (593 citations), Pathology and Forensic Medicine (454 citations) and Surgery (1.0k citations). Richard D. Kim has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Amit Mahipal, Dae Won Kim, Chetasi Talati, Michael Andrew Morse, Aiwu Ruth He, Weijing Sun, Richard S. Finn, Paolo Abada, Michael J. Schell and Federico Aucejo. Their work appears in journals such as Cancers, The Oncologist, Cancer, Expert Opinion on Investigational Drugs and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.